See more : Hosokawa Micron Corporation (6277.T) Income Statement Analysis – Financial Results
Complete financial analysis of Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Zhejiang Hisoar Pharmaceutical Co., Ltd., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Meghmani Organics Limited (MOL.NS) Income Statement Analysis – Financial Results
- Euro Sun Mining Inc. (ESM.TO) Income Statement Analysis – Financial Results
- CITIC Resources Holdings Limited (1205.HK) Income Statement Analysis – Financial Results
- China Evergrande Group (EGRNY) Income Statement Analysis – Financial Results
- CPH Chemie + Papier Holding AG (0QNZ.L) Income Statement Analysis – Financial Results
Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ)
About Zhejiang Hisoar Pharmaceutical Co., Ltd.
Zhejiang Hisoar Pharmaceutical Co., Ltd., a pharmaceutical company, produces and sells fine chemicals and special raw drugs in China and internationally. It offers antibiotic, anti-virus, cardiovascular, sugar-reducing, and other materials; and medicine intermediates, and other customized and processed products, such as clindamycin, 4-AA Iso-carbapenem series, thiamphenicol, florfenicol, voglibose, eclindamycin, 4-AA iso-carbapenem, thiamphenicol, florfenicol, voglibose, etc. It also exports its products. The company was founded in 1966 and is based in Taizhou, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.17B | 2.70B | 2.48B | 2.47B | 2.94B | 2.72B | 2.31B | 2.43B | 2.46B | 1.32B | 1.16B | 1.15B | 1.30B | 1.07B | 893.37M | 1.06B | 1.03B | 770.21M | 690.76M | 506.10M | 373.75M |
| Cost of Revenue | 1.98B | 1.98B | 1.56B | 1.35B | 1.46B | 1.51B | 1.32B | 1.37B | 1.33B | 908.32M | 946.48M | 920.88M | 986.60M | 791.94M | 726.20M | 924.26M | 894.59M | 633.25M | 552.74M | 412.07M | 306.68M |
| Gross Profit | 189.17M | 720.27M | 925.44M | 1.12B | 1.48B | 1.21B | 991.53M | 1.07B | 1.14B | 410.82M | 214.21M | 224.50M | 311.84M | 282.65M | 167.17M | 138.73M | 140.30M | 136.96M | 138.02M | 94.03M | 67.07M |
| Gross Profit Ratio | 8.71% | 26.64% | 37.24% | 45.42% | 50.26% | 44.39% | 42.94% | 43.78% | 46.23% | 31.14% | 18.46% | 19.60% | 24.02% | 26.30% | 18.71% | 13.05% | 13.56% | 17.78% | 19.98% | 18.58% | 17.94% |
| Research & Development | 115.56M | 148.49M | 167.77M | 134.72M | 124.48M | 113.07M | 108.31M | 113.84M | 120.60M | 86.82M | 56.60M | 44.26M | 46.92M | 43.81M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 101.36M | 99.73M | 98.68M | 109.31M | 86.54M | 73.68M | 66.57M | 76.81M | 70.45M | 35.48M | 39.38M | 37.04M | 32.68M | 23.84M | 95.81M | 69.35M | 54.74M | 33.69M | 40.66M | 26.95M | 25.27M |
| Selling & Marketing | 29.22M | 26.28M | 26.72M | 24.87M | 59.62M | 43.78M | 39.27M | 37.94M | 36.37M | 23.91M | 17.21M | 16.95M | 16.93M | 18.35M | 13.07M | 12.70M | 12.21M | 9.67M | 7.65M | 6.94M | 5.28M |
| SG&A | 331.65M | 126.02M | 125.39M | 134.17M | 146.16M | 117.46M | 105.85M | 114.76M | 106.82M | 59.40M | 56.60M | 53.99M | 49.61M | 42.19M | 108.88M | 82.06M | 66.95M | 43.35M | 48.31M | 33.89M | 30.55M |
| Other Expenses | 203.00M | 295.50M | 477.47M | 389.48M | 297.42M | -8.55M | -4.82M | 9.70M | 12.07M | 4.73M | 10.06M | 22.74M | 7.31M | 4.90M | 1.94M | 413.20K | 766.11K | 3.50M | -2.41M | -1.26M | 1.09M |
| Operating Expenses | 653.42M | 570.01M | 770.64M | 658.37M | 568.06M | 524.76M | 480.58M | 555.25M | 522.15M | 286.91M | 218.79M | 184.12M | 172.67M | 156.98M | 112.68M | 84.65M | 71.11M | 46.08M | 50.13M | 33.95M | 30.56M |
| Cost & Expenses | 2.64B | 2.55B | 2.33B | 2.01B | 2.03B | 2.04B | 1.80B | 1.92B | 1.85B | 1.20B | 1.17B | 1.10B | 1.16B | 948.92M | 838.88M | 1.01B | 965.70M | 679.32M | 602.87M | 446.02M | 337.25M |
| Interest Income | 68.13M | 33.47M | 33.00M | 30.87M | 41.77M | 44.37M | 37.12M | 7.45M | 1.55M | 4.42M | 2.16M | 1.57M | 1.27M | 1.09M | -0.99 | -0.49 | -0.87 | 1.96M | 647.29K | 1.13M | -0.23 |
| Interest Expense | 39.62M | 36.55M | 21.89M | 11.36M | 15.51M | 42.59M | 55.02M | 51.13M | 18.63M | 58.23M | 44.21M | 29.31M | 13.88M | 10.55M | 14.78M | 22.21M | 15.42M | 16.35M | 11.56M | 10.92M | 6.46M |
| Depreciation & Amortization | 364.60M | 335.85M | 293.36M | 256.80M | 202.19M | 191.40M | 181.33M | 196.51M | 180.96M | 117.89M | 82.81M | 60.70M | 54.23M | 49.20M | 43.76M | 37.84M | 28.48M | 21.21M | 16.79M | 13.41M | 9.62M |
| EBITDA | -43.99M | 508.56M | 447.85M | 682.57M | 1.07B | 939.31M | 681.90M | 583.70M | 823.83M | 243.49M | 28.95M | 116.11M | 195.00M | 160.67M | 98.26M | 91.92M | 97.66M | 112.57M | 101.91M | 74.18M | 46.12M |
| EBITDA Ratio | -2.03% | 21.33% | 18.31% | 27.34% | 38.93% | 34.96% | 27.61% | 26.23% | 34.18% | 18.46% | 6.78% | 10.68% | 15.09% | 16.18% | 11.79% | 8.87% | 9.66% | 14.61% | 14.75% | 14.66% | 12.34% |
| Operating Income | -464.24M | 240.39M | 122.04M | 395.27M | 918.82M | 710.85M | 399.67M | 327.26M | 613.17M | 61.34M | -102.71M | 3.32M | 120.88M | 99.83M | 34.04M | 29.76M | 47.73M | 74.06M | 77.33M | 51.59M | 32.66M |
| Operating Income Ratio | -21.38% | 8.89% | 4.91% | 15.99% | 31.24% | 26.15% | 17.31% | 13.45% | 24.88% | 4.65% | -8.85% | 0.29% | 9.31% | 9.29% | 3.81% | 2.80% | 4.61% | 9.62% | 11.19% | 10.19% | 8.74% |
| Total Other Income/Expenses | -1.98M | -139.59M | 9.52M | -1.76M | -6.37M | -13.56M | -316.00 | 6.28M | 11.08M | 3.92M | 4.65M | 22.78M | -11.68M | -14.63M | -20.19M | -24.40M | -20.68M | 822.68K | -15.69M | -10.69M | 375.98K |
| Income Before Tax | -466.22M | 100.80M | 123.03M | 393.51M | 912.45M | 697.30M | 399.86M | 334.71M | 624.24M | 65.27M | -98.07M | 24.60M | 126.89M | 100.33M | 34.30M | 29.69M | 48.50M | 74.95M | 73.56M | 49.86M | 33.04M |
| Income Before Tax Ratio | -21.47% | 3.73% | 4.95% | 15.92% | 31.02% | 25.65% | 17.32% | 13.75% | 25.33% | 4.95% | -8.45% | 2.15% | 9.77% | 9.34% | 3.84% | 2.79% | 4.69% | 9.73% | 10.65% | 9.85% | 8.84% |
| Income Tax Expense | -44.64M | 14.73M | 29.17M | 73.81M | 141.67M | 92.29M | 57.51M | 110.15M | 114.74M | 20.61M | 1.20M | 4.37M | 22.84M | 14.46M | 3.96M | 4.20M | 17.06M | 22.17M | 23.20M | 14.16M | 10.17M |
| Net Income | -420.06M | 88.01M | 95.23M | 319.72M | 770.78M | 605.00M | 342.22M | 225.02M | 516.59M | 53.52M | -82.11M | 22.78M | 105.06M | 85.63M | 30.30M | 25.60M | 31.05M | 52.11M | 49.60M | 35.13M | 22.42M |
| Net Income Ratio | -19.34% | 3.25% | 3.83% | 12.94% | 26.20% | 22.25% | 14.82% | 9.25% | 20.96% | 4.06% | -7.07% | 1.99% | 8.09% | 7.97% | 3.39% | 2.41% | 3.00% | 6.77% | 7.18% | 6.94% | 6.00% |
| EPS | -0.26 | 0.05 | 0.06 | 0.20 | 0.48 | 0.38 | 0.22 | 0.15 | 0.36 | 0.07 | -0.13 | 0.04 | 0.17 | 0.13 | 0.05 | 0.04 | 0.05 | 0.11 | 0.10 | 0.07 | 0.12 |
| EPS Diluted | -0.26 | 0.05 | 0.06 | 0.20 | 0.48 | 0.38 | 0.21 | 0.15 | 0.36 | 0.07 | -0.12 | 0.04 | 0.17 | 0.13 | 0.05 | 0.04 | 0.05 | 0.11 | 0.10 | 0.07 | 0.12 |
| Weighted Avg Shares Out | 1.62B | 1.62B | 1.62B | 1.62B | 1.61B | 1.59B | 1.56B | 1.50B | 1.43B | 764.56M | 656.86M | 650.87M | 636.75M | 646.25M | 637.93M | 639.93M | 653.70M | 485.14M | 489.33M | 489.33M | 1.62B |
| Weighted Avg Shares Out (Dil) | 1.62B | 1.62B | 1.62B | 1.62B | 1.61B | 1.59B | 1.63B | 1.50B | 1.43B | 764.56M | 656.86M | 650.87M | 636.75M | 646.25M | 637.93M | 639.93M | 653.70M | 485.14M | 489.33M | 489.33M | 1.62B |
No news found for: 002099.SZ
Source: https://incomestatements.info
Category: Stock Reports